An advisory panel, stacked with RFK Jr.’s pro-peptide appointees, has voted to add BPC-157 and KPV to the bulk compounding list. This is despite FDA staff clinicians stating that there’s no convincing evidence. Central to the argument is whether allowing compounding will curtail the gray market or expose the public to unnecessary risk. Internally screaming.
Victoria Song

Senior Reviewer, Wearable Tech
Senior Reviewer, Wearable Tech
More From Victoria Song

A new lawsuit charges the company with duping customers. Who’s at fault?

I’ve tried nearly everything under the sun to get my cat Pablo to lose weight. I’m not winning this battle.
I sat down with Google to discuss its vision for the next generation of wearables. It’s a work in progress.
8
Verge Score
Think of this as part one of the Pixel Watch 5 review as most of the new features aren’t out yet. That said, GPS rocks.

Going screenless proves you can afford to be intentionally inefficient.
We’re ready for some bad jokes during Google’s celebrity-packed live show.
We’re talking offline Gemini, proactive AI suggestions, better GPS maps, insulin resistance trends, and a $50 price hike.

Its recent attempts to shore up privacy don’t seem to be convincing skeptics.

Living an optimized, self-quantified life can get a little out of hand.